Tin tức & Cập nhật

Neoadjuvant cycles do not alter perioperative nivolumab benefit in resectable NSCLC
Neoadjuvant cycles do not alter perioperative nivolumab benefit in resectable NSCLC
02 Jul 2024
Subcutaneous atezolizumab favoured over intravenous infusion
Subcutaneous atezolizumab favoured over intravenous infusion
02 Jul 2024 bởiJairia Dela Cruz

Nonsmall cell lung cancer (NSCLC) patients with high PD-L1 expression appear to show a strong preference for receiving atezolizumab subcutaneously rather than intravenously.

Subcutaneous atezolizumab favoured over intravenous infusion
02 Jul 2024
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
01 Jul 2024 bởiSarah Cheung

New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.

Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
01 Jul 2024